Stay updated on ARGX-113 in Myasthenia Gravis: Safety Trial
Sign up to get notified when there's something new on the ARGX-113 in Myasthenia Gravis: Safety Trial page.

Latest updates to the ARGX-113 in Myasthenia Gravis: Safety Trial page
- ChecktodayChange DetectedThe study record no longer lists the U.S. NIH grant/contract identifier “2018,” and the site revision label changed from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe study record for the ARGX-113 follow-on trial in generalized myasthenia gravis is displayed, including its eligibility criteria, locations, design, outcomes, results-related dates, and study documents.SummaryDifference66%

- Check21 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check28 days agoChange DetectedA banner announces that NIH content is transitioning from the term “Artificial Intelligence” to “Super Intelligence.” It appears above the unavailable study record.SummaryDifference1%

- Check35 days agoChange DetectedThe footer revision number changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check42 days agoChange DetectedThe ClinicalTrials.gov study page is showing a 403 Forbidden response instead of its study content.SummaryDifference0.2%

Stay in the know with updates to ARGX-113 in Myasthenia Gravis: Safety Trial
Enter your email address, and we'll notify you when there's something new on the ARGX-113 in Myasthenia Gravis: Safety Trial page.